We describe the protocol development and optimization of asymmetric-flow field-flow fractionation (AF4) technology for separating and characterizing extracellular nanoparticles (ENPs), particularly small extracellular vesicles (sEVs), known as exosomes, and even smaller novel nanoparticles, known as exomeres. This technique fractionates ENPs on the basis of hydrodynamic size and demonstrates a unique capability to separate nanoparticles with sizes ranging from a few nanometers to an undefined level of micrometers. ENPs are resolved by two perpendicular flows-channel flow and crossflow-in a thin, flat channel with a semi-permissive bottom wall membrane. The AF4 separation method offers several advantages over other isolation methods for ENP analysis, including being label-free, gentle, rapid (<1 h) and highly reproducible, as well as providing efficient recovery of analytes. Most importantly, in contrast to other available techniques, AF4 can separate ENPs at high resolution (1 nm) and provide a large dynamic range of size-based separation. In conjunction with real-time monitors, such as UV absorbance and dynamic light scattering (DLS), and an array of postseparation characterizations, AF4 facilitates the successful separation of distinct subsets of exosomes and the identification of exomeres. Although the whole procedure of cell culture and ENP isolation from the conditioned medium by ultracentrifugation (UC) can take~3 d, the AF4 fractionation step takes only 1 h. Users of this technology will require expertise in the working principle of AF4 to operate and customize protocol applications. AF4 can contribute to the development of high-quality, exosome-and exomere-based molecular diagnostics and therapeutics.
advanced characterization of molecular signatures associated with each subset of ENPs will facilitate these areas of research.
To date, various strategies have been developed in an attempt to isolate pure EV subpopulations, especially exosomes; these include differential UC (dUC), immuno-affinity capture (IAC), ultrafiltration (UF) and size-exclusion chromatography (SEC), polymer-based precipitation and microfluidics [19] [20] [21] [22] [23] [24] . However, the purity, yield and integrity of isolated exosomes, as well as the labor-and time-efficiency of the techniques remain to be improved. AF4 exhibits unique capabilities to separate nanoparticles and has been widely utilized to characterize nanoparticles and polymeric nanoparticles in the pharmaceutical industry, as well as being used to characterize biological macromolecules, protein complexes and viruses 25, 26 . In this protocol, we provide a detailed description of the method development and optimization of AF4 for characterizing and separating exomeres and exosome subpopulations used in our previously published work 11 .
Overview of the procedure and development of the AF4 protocol
The technique of field-flow fractionation (FFF) was first developed by Giddings in 1966 (ref. 27 ) and further evolved into a class of flexible analytical fractionating techniques with unique capabilities to separate analytes ranging from a few nanometers to~100 µm in size with high resolution 25 . The separating device is usually a thin, flat channel with a height varying between 50 µm and 500 µm. A parabolic laminar channel flow is generated that carries the samples forward from the inlet to the outlet (Fig. 1) . Perpendicular to the forward channel flow, an external physical field is applied to the channel to drive the accumulation of samples at the bottom wall. However, the counteracting Brownian motion of the molecules results in their diffusion toward the channel's interior. Therefore, the equilibrium of these two driving forces resolves the samples at different layers within the channel relative to the bottom wall and elutes them out at varying time points. The more elevated the samples are from the bottom wall, the faster the flow rate of the laminae in which the samples reside. As a result, particles at higher positions will be eluted out of the channel earlier as compared to less elevated particles. Different types of external fields, such as a gravitational field generated by centrifugation, a temperature difference, an electric field and cross-flow, have been applied to separate samples on the basis of different inherent biophysical properties [28] [29] [30] [31] [32] . AF4 was then developed on the basis of flow FFF by Granger, Wahlund and Giddings in the 1980s 33, 34 . In AF4, the bottom wall is replaced with a semi-permissive membrane with a specific The part sizes shown in the figure are for illustration only and not drawn to scale. a, In the focus stage, two flows in opposing directions (fine blue arrows) are pumped into the channel from the inlet and outlet ports and balanced near the injection port. Samples are injected during the focus stage and focused in a thin band by the two opposing flows. Particles reach heights related to their diffusion coefficients. b, In the elution stage of the normal mode, a single direction of channel flow from the inlet to the outlet is applied, and particles with small hydrodynamic size and high diffusion coefficient are eluted at an early time point, whereas particles with large hydrodynamic size and low diffusion coefficient elute later. c, When the physical size of a particle is too large, as compared to the channel height, to be considered as a point mass, it elutes in the steric mode. In contrast to the normal mode shown in b, in steric mode large particles elute earlier than the smaller ones. The fine blue arrows indicate the channel flow (horizontal arrows) and cross-flow (vertical arrows); the fine black arrows illustrate the channel flow carrying the ENPs through the channel during the elution step (the lengths of the arrows represent the magnitude of the flow rate); the thick blue arrows represent the inlet and outlet flows; and the red-outlined arrows depict the injection flow (the filled arrow indicates the injection flow is ON, and the empty arrows indicate the injection flow is OFF). All the arrowheads point in the flow direction. The fine green arrows indicate the direction of particle movement caused by the cross-flow; the fine red arrows in b and c indicate the direction of particle movement due to their diffusion (b) or the physical position of the particles in the channel due to their physical sizes (c). R h , hydrodynamic radius.
cutoff size, allowing the penetration of solvent and small molecules below the cutoff size but retaining sample components larger than the cutoff size. The cross-flow, perpendicular to the forward channel flow, is the driving force for sample accumulation at the bottom wall (the membrane, in this case). The separation of samples is solely determined by the differences in their inherent diffusion coefficients. The adjustable cross-flow makes AF4 a powerful fractionating technique with great flexibility to accommodate samples with a large size range. Also, owing to its compatibility with both organic and aqueous buffers, AF4 has been widely utilized to characterize biological and non-biological analytes, such as proteins, plasmids, polysaccharides, lipoproteins, virus and virus-like particles, liposomes and various polymers [35] [36] [37] [38] [39] [40] . However, to date, AF4 has been rarely tested for EV analysis. Although a few studies use AF4 to analyze exosomes, these studies are limited by their small sample size and a lack of thorough characterization of the biophysical and molecular properties of exosome fractions required for method optimization [41] [42] [43] [44] . The purpose of our work is to develop the AF4 method and optimize the instrumental parameters used to separate and characterize exosome subpopulations and exomeres. Our protocol can also serve as a reference for further modifications for other types of ENP analysis.
Because the volume limit of sample injection is determined by the injection loop size (100 µL in our instrumental setting), and because of the complexity of the sample composition and the desired resolution (to separate exosome subpopulations, in our case), we chose ENPs derived from cultured cells and prepared them using dUC. This method enriched for exosomes as the input samples. In brief, conditioned medium from the cultured murine melanoma cell line B16-F10 was collected and subjected to a sequential centrifugation at 500g for 10 min to remove cells and cell debris, at 12,000g for 20 min to remove large EVs such as microparticles and large oncosomes, and finally at 100,000g to pellet ENPs that are still heterogeneous in particle size but enriched for exosomes and exomeres. The pelleted samples were washed once and resuspended in PBS, ready for AF4 fractionation. Real-time detectors for UV absorbance and quasi-elastic (dynamic) light scattering (QELS) were installed for real-time determination of the fractionated particle concentration and hydrodynamic size, respectively. Post-separation characterization, including DLS measurement in batch mode, nanosight tracking analysis (NTA), transmission electron microscopy (TEM) and other biophysical/biochemical analyses, was also used to validate the fractionation quality and further characterize the separated ENPs, as described previously 11 . However, these post-separation characterization methods are not detailed in this protocol.
Through our pilot studies, we evaluated the influence of several key parameters of AF4 that were shown to be critical for high-resolution separation of distinct exosome subsets. These included crossflow, channel height, sample focusing, type of membrane and the amount of loaded sample. These factors collectively determine fractionation quality, and changing one parameter usually affects the influence of other factors on resolution power. Testing different combinations of these factors, however, can be expensive, time consuming and labor intensive, and thus can be impractical. Understanding the working principles of AF4 and determining the complexity of the analyzed samples (e.g., prior examination by electron microscopy, NTA and/or western blotting analysis of markers of potential constituents) will be useful in guiding the method development process.
Cross-flow
According to the AF4 theory, cross-flow is the driving force counteracting the Brownian motion of particles to resolve particles with different hydrodynamic sizes at different channel-flow laminae at steady state. Thus, cross-flow is a defining factor in AF4 fractionation quality. To determine the optimal cross-flow for exosome fractionation, we evaluated various cross-flow settings. We devised exosome fractionation profiles (fractograms of UV absorbance and DLS) from representative crossflow settings, as shown in Fig. 2 . Specifically, we examined linear gradients of cross-flow with different starting flow rates (at 0.3, 0.5 and 1.0 mL/min) and slopes (i.e., how quickly the cross-flow dropped to 0 mL/min; tested conditions: a decrease in flow rate from 0.5 to 0 mL/min within 15, 30 and 45 min).
As shown in Fig. 2a , a linear separation of the sEV mixture was achieved when the cross-flow decreased from 0.5 to 0 mL/min within 45 min. In this graph, the hydrodynamic radius (R h ; black dots, y axis) was plotted along the time course (x axis). The red (QELS) and blue (UV) lines show the total intensity of DLS and UV absorbance (indicating the protein concentration and abundance of particles) at each time point, respectively. Both QELS and UV absorbance are shown in a relative scale to illustrate the relative abundance of each subpopulation in the same sample, and therefore the axes are not shown. Based on the properties of the DLS data collected at each time point, Astra 6 deduced the corresponding hydrodynamic size of the particles resolved at each time point and plotted them along the y axis (black dots). Under this specific AF4 setup, three major peaks (P2, P3 and P4) were observed. These peaks represented the exomeres and two exosome subsets (i.e., small exosomes (Exo-S) and large exosomes (Exo-L)), respectively, as reported in our previous work 11 . Proteomic characterization of these sEV subsets has revealed the enrichment of markers of endosomal origin, especially in the Exo-S subpopulation, indicating the enrichment of bona fide exosomes in this subset separated via AF4 (ref. 11 ), whereas the Exo-L subpopulation has characteristics of both exosomes and EVs potentially >150 nm, suggesting that they may represent non-canonical exosomes or probably sEVs of different subcellular origins 11 . Among the other peaks, P0 is the void peak, resulting from flow disturbance when switching from the focus/injection mode to the elution mode. P1 is a very minor peak, generated by the concomitant elution of the void peak and species that were smaller than exomeres. Depending on the ENP preparation, P1 was sometimes barely detected. P5 was generated due to loss of control on flow rate when it decreased below~0.08 mL/min and all retained sample components (larger microparticles and/or aggregates of small particles) were eluted out. Representative AF4 fractionation profiles of B16-F10 sEVs collected by applying a linear cross-flow gradient with an initial flow rate at 0.3 mL/min (blue line), 0.5 mL/min (red line) or 1.0 mL/min (black line) and dropping to 0 mL/min over 45 min. c, Representative AF4 fractionation profiles of B16-F10 sEVs collected by applying a linear cross-flow gradient with an initial flow rate at 0.5 mL/min and dropping to 0 mL/min over 15 min (blue), 30 min (black) or 45 min (red). b,c, Top, QELS at 100°; bottom, UV absorbance at 280 nm. The other AF4 parameters are channel flow rate, 1.0 mL/ min; channel height, 490 μm; sample focus time, 2 min; membrane, regenerated cellulose (RC); input amount, 40 μg. QELS, quasi-elastic (dynamic) light scattering; Vx, cross-flow rate.
To elucidate, AF4 is highly reproducible and yields almost identical fractograms of both UV absorbance and QELS if the same sample is analyzed repeatedly under identical conditions 11 . However, we have observed that factors such as cell culture conditions, nutrient availability and passage number of cell lines may influence the biogenesis and release of ENPs from particular cell lines 11 . One consequence is that the relative abundance of different subpopulations of ENPs may vary, reflected by the peak size of AF4 fractograms. The differences between the AF4 fractograms observed in Fig. 2a and Fig. 2b ,c when the same AF4 method (Vx (cross-flow rate) = 0.5 mL/min; gradient time = 45 min) was used for fractionation are mainly due to the differences between the two independent biological samples. Furthermore, peaks identified on the AF4-UV charts of samples resolved under diverse conditions examined below (data demonstrated in Figs. 2-6 ; Astra 6 data files are provided at https://figshare.com/s/6f22aede51fb279a3f81) in this protocol, as compared with those in Fig. 2a , were labeled as peaks P2-P5 in a similar manner. However, the quality/resolution of matching peaks between samples resolved under varying conditions can be divergent.
As shown in Fig. 2b , when the initial cross-flow rate was increased to 1.0 mL/min, no additional shoulder peaks were observed to separate further from peaks P2-P4, indicating the uniformity of these three populations of particles. A delay in the elution of all three peaks was observed. Moreover, a much higher P5 peak was observed, and this is due to insufficient time for elution of large particles, including Exo-L, in the given time and on the basis of channel size. By contrast, when the initial cross-flow rate was set to 0.3 mL/min, the samples eluted much earlier, indicating that this flow rate was not fast enough to retain the sample constituents inside the channel and resolve them efficiently. Therefore, an initial cross-flow rate of 0.5 mL/min was used throughout the procedure.
Next, we evaluated the impact of different slopes of the cross-flow gradient on separation quality. We compared linear decreases of the cross-flow rate from 0.5 to 0 mL/min within time spans of 15, 30 and 45 min. Clearly, the peaks became narrower and the separation quality was compromised when shorter time spans were used (Fig. 2c) . When a time span of 15 min was used, samples were incompletely resolved and only one peak was partially eluted before elution of peak P5, as shown clearly in Fig. 2c , bottom chart (blue line and dots). The maximum hydrodynamic diameter of resolved ENPs is <80 nm. In addition, a larger P5 peak was observed when a shorter time span was used, indicating insufficient time for separation and elution of large particles. The resolution improved when the gradient time span was increased, as we observed an increase of the size range of separated ENPs, a smaller peak P5, and more peaks of fractionated samples resolved. When we used longer time spans, the peaks broadened, but showed improved separation quality. This setting is desirable when high-purity particles in discrete fractions need to be recovered for further post-separation characterization. However, when longer time spans are used, other practical issues, such as the dilution of samples and the sensitivity limit of real-time detectors for accurate measurement, have to be taken into account. Based on this consideration, and given the successful separation of distinct subsets of exosomes and exomeres, we chose the linear gradient of the cross-flow decreasing from 0.5 to 0 mL/min within 45 min for our study and did not test longer time spans.
Channel height
Based on the working principle of AF4, the channel's geometry, including its width, height and shape, is critical to fractionation quality. The short channel utilized in our study, a product of Wyatt Technology, has a trapezoidal geometry 45, 46 with a tip-to-tip length of 152 mm and a linear decrease of the channel width from 21.5 mm (close to the injection port and~12 mm away from the inlet tip) to 3 mm. With the shape and width already optimized and fixed, the height (i.e., the thickness of the channel, determined by the spacer used between the upper wall and the bottom accumulation membrane) is the only parameter available for further optimization. A series of spacers with different thicknesses (190, 250, 350 and 490 µm) are provided by the manufacturer. The channel height affects the parabolic laminar flow rate profile and thus the separation resolution. It also affects the channel capacity, with a thicker channel allowing analysis of larger sample amounts. Because we needed to recover enough sample for downstream analysis, the loading capacity is an important factor for our fractionation and so we considered use of only spacers with a thickness of 350 or 490 µm. As shown in Fig. 3 , the channel with the 350-µm spacer eluted the samples earlier, but with narrower peaks and a reduced separation resolution as compared with the channel with the 490-µm spacer. Therefore, we chose the 490-µm spacer for our work.
Focusing
We used a 100-µL sample loop in our instrument for sample loading. It is a substantial portion of the total channel capacity, which usually ranges from 200 to 1,000 µL. Once injected into the channel, the sample would spread throughout the channel and lead to insufficient fractionation. To avoid this, a flow opposing the channel forward flow was introduced from the outlet, and, together with the channel flow, it focused the sample into a narrow band close to the injection port (i.e., focus mode). First, the focus flow was established and then the samples were injected in the focus mode and given enough time to reach steady-state equilibrium before elution. The focusing flow rate and focusing time determine focusing efficiency. Here, we fixed the focusing flow rate at 0.5 mL/min, the same as the initial cross-flow rate for elution, and then tested different time periods (2, 5 and 10 min) for focusing efficiency. As shown in Fig. 4 , different focusing times did not affect peak shape or resolution power. Moreover, before exomere elution occurred, the fractograms of both UV absorbance and DLS reached similar baselines. Notably, we observed that the P5 signal intensity increased as focusing time increased, suggesting potential particle aggregation caused by extensive focusing. Therefore, we chose a focusing time of 2 min for our study.
Membrane choice
Because the sample fractionation is performed close to the membrane, in addition to the pore size (which should be below the size of the smallest solute being fractionated in your sample) of the membrane, the compatibility of the membrane material with the samples also needs to be considered. For example, the sample may bind to the membrane nonspecifically. We tested two different types of membranes that are commonly used for biological material concentration or filtration, regenerated cellulose (RC) and polyethersulfone (PES), for exosome fractionation. While keeping other AF4 parameters exactly the same, we observed a delay of sample elution and broader peaks in the channel with PES as compared with RC, suggesting potential nonspecific interactions between samples and the membrane (Fig. 5) . Therefore, we selected the RC membrane for our studies. 
Amount of input sample
Once we determined the key fractionation parameters, we then examined the loading capacity of AF4. The minimal amount of material required for AF4 is determined primarily by the sensitivity limit of the real-time detectors, such as the DLS and UV monitors. The signal/noise ratio must be adequate for accurate data collection and interpretation. The maximal amount of material is determined by the required resolution of fractionation, which depends on the purpose of the experiment and the complexity of the sample to be analyzed. To efficiently separate exomeres and the two exosome subsets that we reported previously 11 from sEVs prepared using dUC, we tested different amounts of B16-F10-derived sEV input samples ranging from 15 to 165 µg. As shown in Fig. 6 , 15 µg was the lower limit of material for this analysis, as we started to detect a high level of noise, especially at the low end of hydrodynamic size. Inputs of 40 µg and 100 µg yielded almost identical fractionation profiles and hydrodynamic size determinations, indicating comparable fractionation resolution and robust signal detection. However, when the amount of input increased to 165 µg, the elution of all peaks was delayed significantly, resulting in incomplete elution of Exo-L. Bleed-through of each particle population to the adjacent populations increased (and thus poorer separation occurred), as indicated by the increased signal intensity at the valleys between peaks. Therefore, an input ranging from 40 to 100 µg was used for this study.
Applications of the method
As illustrated in the above assessments and in our previous publication 11 , AF4 technology provides unique capabilities to separate nanoparticles with high resolution within a large size range, and we show that AF4 can separate distinct exosome subpopulations and exomeres. Our findings exhibit the potential of AF4 methodology in identifying other distinct EV subpopulations. Coupled with realtime monitoring (e.g., multi-angle light scattering (MALS), DLS, UV absorbance and fluorescence detection) and post-separation analyses (e.g., microscopy; mass spectrometry of proteins, lipids, glycans and metabolites; and DNA and RNA sequencing), AF4 can yield valuable data about ENP analytes, including particle morphology and size, relative abundance, molecular composition and other biophysical and biochemical properties. AF4 can help researchers decipher the complexities and heterogeneity of ENPs that cannot be well addressed with other existing techniques. Our AF4 protocol describes the fractionation of exomeres and exosome subsets from sEVs isolated from the conditioned medium of B16-F10 cells and a panel of more than 20 different cancer cell lines and five normal cell lines (see Supplementary Table 1 in ref. 11 for the detailed list of cell lines examined and unpublished data (H.Z. and D.L.) on normal mouse and human mammary epithelial cell lines CommaD (mouse), HMEC124 (human) and HMEC240L (human)). The characterization of exomeres, Exo-S and Exo-L isolated from five cancer cell lines (i.e., B16-F10, 4T1, Pan02, MDA-MB-4175 and AsPC-1) was reported previously 11 . The AF4 fractionation analysis of sEVs isolated from additional cell lines also indicates the detection and separation of exomeres, ExoS and Exo-L as reported in our previous work 11 . This AF4 method can be used to fractionate and characterize sEVs isolated from an array of bodily fluids (including blood plasma or serum, lymphatic fluid, bone marrow plasma, cerebrospinal fluid, urine, saliva, bronchoalveolar lavage, milk and amniotic fluid), given their similar particle compositional complexity. Note that AF4 fractionation of sEVs isolated from bodily fluids usually requires prior stratification of the samples to remove confounding substances (e.g., lipoproteins in plasma) with similar-sized sEVs. Because all cells are capable of shedding EVs, our protocol can be used to study the EV biology of any organism.
In addition to its use for biological discovery, our protocol can also be modified for use in the field of quality control in exosome-based pharmaceutical production. Exosomes have become attractive therapeutic delivery vehicles for treating cancer and other types of diseases 47 . AF4 coupled with sensitive molecular assays can serve as an improved analytic tool to evaluate purity, drug loading efficiency and the integrity of the exosome product by detecting debris or aggregates.
Last but not least, this protocol can serve as a reference in the further development and optimization of methods for fractionating and characterizing other types of ENPs. Some unique advantages of AF4 are its high resolution and large size range of fractionation. Furthermore, different conditions, such as cross-flow setting and focus time, can be easily tested by simply programing the settings into the software, with minimal handling of the channel. In addition to their use in analyzing exosomes and other sEVs, fractionation protocols for large EVs, such as larger microparticles and oncosomes, can be further developed. Specific care should be taken when fractionating large particles because they may be too large to elute in the normal mode (when the particle is small and considered as a point mass as compared to the channel height) and may elute in the steric mode instead (Fig. 1) . Moreover, other fields, such as an electric field, can also be applied to AF4 to stratify particles on the basis of biophysical properties other than size, allowing even broader application of AF4 technology.
Taken together, the separation and characterization of distinct EV subpopulations by AF4 are critical to advancing our knowledge of the biology of EVs and their functional roles in physiological and pathological conditions. By profiling the molecular cargo of EVs, we can identify signature proteins, lipids, glycans and genes, as well as specific signaling pathways associated with disease progression, facilitating the identification of potential diagnostic/prognostic biomarkers, including those related to cancers. Such knowledge will also provide a rationale for developing ENP-based therapies in clinical trials.
Comparison with other methods
A multitude of technologies, in addition to AF4, have been developed to isolate pure exosomes and other EV subpopulations. The most commonly used technique makes use of dUC and separates the particles on the basis of their hydrodynamic size and density. Successive centrifugation at different centrifugal forces eliminates dead cells and cellular debris (500g, 10 min), large oncosomes and apoptotic bodies (2,000-3,000g, 20 min) and larger microparticles (10,000-12,000g, 20 min), and subsequently pellets sEVs (100,000g, 70 min) 19, 48, 49 . Centrifuge rotor type, centrifugal force and centrifugation time are key factors influencing the product yield and purity of this method. Its performance also varies depending on the cell types studied 50 . dUC can process large volumes and high amounts of sample, but the purity of the material recovered is poor. It can only roughly partition particles into groups such as large vesicles, microparticles and sEVs (enriched for exomeres and exosomes), with expected heterogeneity within each group and contamination from other groups 19, 24 . The high centrifugal force may also cause sample aggregation. With our protocol, we took advantage of dUC by first stratifying and concentrating the sEV population and then analyzing particles at much higher resolution to further fractionate exomeres and exosome subsets.
Density gradient floatation (DGF) is often used to further purify sEVs first isolated using dUC. In DGF, EVs are overlaid upon a gradient of increasing dilutions of a viscous solution (sucrose or iodixanol are commonly used) and, upon centrifugation, they migrate to the equilibrium density determined by the EV's size, shape and density. DGF is often used to remove non-membranous particles from EVs and has also been used in several studies to address exosome heterogeneity 12, 50, 51 . The major drawbacks of DGF, as compared to AF4, include its time-consuming preparations, lack of automation, operator-dependent reproducibility and low yield 19, 24 . Long periods of incubation with high sucrose concentrations can also damage EV integrity, necessitating additional washing steps for its removal. By contrast, AF4 is rapid, fully automated, highly reproducible, robust and compatible with many buffer choices that mimic physiological conditions. Resolution and size range in EV fractionation is far superior with AF4 than with DGF 24 . SEC, a gentle means of nanoparticle fractionation, has been extensively used for protein and protein complex analysis in biochemical and biophysical studies. Recently, it has been adopted to fractionate EVs [52] [53] [54] [55] . In SEC, particles are separated in a column filled with porous polymer beads (stationary phase) based on their size and shape. Smaller-sized particles with a globular shape can penetrate the porous beads more readily, taking a longer route and more time to elute, whereas the larger particles are excluded from penetrating the pores and subsequently elute more rapidly. The elution of particles with abnormal shapes is more complicated because of its potential steric interference with particles traveling through the pores. Compared to other technologies, SEC has a resolution most similar to that of AF4. Still, AF4 demonstrates superior resolution over a much wider size range 25 . SEC resolution drops when particles are close to or larger than the upper limits of pore size. Furthermore, SEC is not as flexible as AF4 with regard to changing separation parameters, and its size range of separation is fixed for a given column with a specific solitary phase. Moreover, AF4 contains a hollow channel with only a membrane at the accumulation wall but, unlike SEC, requires no stationary phase. This stationary phase in SEC generates shear stress and renders a much larger surface area than AF4 for nonspecific binding of analytes. Similar to AF4 methods, the input sample loading volume for SEC must be restricted and there is an upper limit for the sample capacity, which requires compromise between sufficient yield and exemplary fractionation quality. Sample stratification by dUC and concentration methodologies before separation greatly facilitate the separation power of SEC.
UF allows straightforward isolation of EV populations on the basis of their size by filtering the sample through a series of semipermeable membranes with defined pore sizes (i.e., as reflected by molecular weight cutoffs) 56, 57 . Particles below the cutoff size can penetrate the pores, whereas larger ones are retained. UF provides only a crude separation of EVs because of limitations of membrane pore size availability. Most EVs are not rigid spheres but, rather, are flexible particles and can undergo transfiguration to pass through the pores, especially when pressure is applied. Another concern is the uniformity of membrane pore size, which is critical to separation purity. Although the separation power of UF is inferior to that of AF4, UF can serve as a means to pre-stratify and concentrate input samples for further analysis by AF4.
Distinguishable from methods that separate EVs mainly by their size, IAC relies on the antigenic recognition of EV surface molecules (primarily proteins). IAC is highly selective, fast and flexible, allowing scaling for either preparation or analytic purposes. This separation principle has been adapted for different formats of analysis and preparation, including precipitation using immunomagnetic beads, flow analysis, detection by microarray, microscopy, western or ELISA assay, and microfluidic separation 19, 22, 23, 58 . The inherent limitation of IAC is that knowledge about the surface antigen is a prerequisite. The other concern is that the IAC antigen may be represented in multiple subpopulations of EVs with divergent sizes and/or origins. Thus, the application of AF4 may necessitate further EV separation on the basis of size. EVs captured by IAC are ideal for molecular content characterization but not for further functional studies because of the inefficient removal of the capturing antibody, which may interfere with the functional assay or targeting and uptake by recipient cells. By contrast, AF4 is label-free and makes these functional analyses feasible.
Level of expertise needed to implement the protocol
The AF4 instrument is commercially available (e.g., Wyatt Technology) and the manufacturer can perform the initial setup. The method development for specific sample analysis, routine maintenance of instruments and troubleshooting requires a good understanding of the working principles of AF4 and installed detectors, training for handling the AF4 channel and detectors, and familiarity with the software used for AF4 operation and data collection. Previous experience with chromatography and/ or microfluidics is helpful in mastering the AF4 application. However, once the AF4 fractionation method training has been completed, only minimal skills, such as familiarity with the software interface and proper instructions, are necessary to complete the fractionation process because nearly all the steps are automatic and programmed.
Limitations
One inherent limitation of AF4 is that it fractionates samples on the basis of their size. As a consequence, particles with the same hydrodynamic size but with different morphologies, surface molecules and other biophysical properties cannot be separated from each other via AF4 alone. However, other fields, such as an electric field, can also be applied in conjunction with AF4 to provide further separation according to additional characteristics such as particle surface charge. Special consideration is also required when developing a protocol for particles whose sizes are too large to be considered as point mass as compared to the channel height. These large particles will elute in the steric mode rather than the normal mode, as illustrated in Fig. 1 .
A second inherent drawback is that AF4 can accommodate only small amounts of sample (e.g., 40-100 μg), which is often not efficient for large-scale preparations in more detailed assessments of nanoparticle properties. The sample instead can be divided into multiple fractionation analyses for improved characterization of specific nanoparticle subsets. A third limitation of AF4 is that, owing to the loading capacity limitation, the input sample requires UC preparation or other means to first stratify and concentrate the analytes (i.e., sEVs in our study) before fractionation.
Furthermore, no single formula can be universally applied for analysis of different types of samples. The fractionation method and key parameters discussed above in the 'Overview of the procedure and development of the AF4 protocol' section must be developed and optimized on the basis of the complexity (i.e., size and abundance of each component) of the sample of interest. In certain cases, different running methods and instrument settings may have to be combined sequentially to efficiently separate different components within a complex sample.
Experimental design
Preparation of sEVs from cell culture With the aim of separating distinct cellular nanoparticles, such as exomeres and exosome subsets, we decided to study sEVs isolated using dUC as the input samples for AF4 because of dUC's capability to process large volumes of samples and its short preparation time. Alternative methods, such as DGF, UF and SEC, can also be used for sEV input sampling. EVs captured by IAC can be applied as well, if the antibody can be removed from the EVs.
This protocol was developed and optimized using sEVs derived from cell culture model systems. Conditioned medium is sequentially spun to remove cells, cell debris and large EVs and finally pellet down the sEVs. We have previously reported that fresh versus frozen sEV samples do not markedly differ in AF4 profiles 11 , indicating that the structural integrity of EVs is well preserved during the freeze-thaw process. Of note, the culture conditions, such as hypoxic conditions, and the passage of cells can influence EV production and composition (i.e., the percentage of each particle type in a sample) 11 . Therefore, these changes in ENP composition may require modifications of the AF4 methods for further optimization to achieve the desired separation quality.
As stated in the 'Applications of the method' section, this protocol could also be applied to sEVs prepared from other sources, such as bodily fluids, including plasma, in conjugation with other means of prior stratification of the samples. AF4 parameters such as the cross-flow gradient can be further adjusted to meet the specific requirements of particular samples (e.g., existence of additional types of ENPs). However, for certain sample types, the EV composition is more complex than that derived from conditioned medium of cell cultures. For example, the presence of lipoprotein particles in blood plasma may interfere with the separation of exosomes because of their partial overlap in size. In this case, another means (such as IAC) of prior removal of lipoproteins from the plasma sample is desirable before their further fractionation via AF4.
AF4 fractionation of sEVs and real-time data collection and analysis
The AF4 method for separation of exomeres and exosome subsets (i.e., Exo-S and Exo-L) from cell culture-derived sEVs is illustrated in Fig. 7 and Table 1 . On the basis of the complexity of the EV samples and the goal of each specific study, this running method can be further adjusted, as described in the 'Overview of the procedure and development of the protocol' section.
For real-time monitoring and analysis of the fractionation of particles, several real-time detectors are usually installed immediately after the AF4 channel. Our laboratory has the Dawn Heleos II (MALS detector, Wyatt Technology) with QELS (DLS detector) installed at the detector 12 (100°) position and an Agilent 1260 Infinity Multiple Wavelength Detector (set to 280 nm for UV absorbance detection) in place. We use the DLS measurement mainly to determine the hydrodynamic size of the fractionated particles in real time. The primary data from a DLS measurement are encompassed by the autocorrelation function, which plots the average overall changes in the scattered 
where τ is the delay time, β is the intercept of the correlation function, q is the scattering factor, n 0 is the refractive index of the solution, λ 0 is the laser wavelength and θ is the scattering angle. Based on the Stokes-Einstein relation (below), we can further deduce an effective R h from D t :
where k is the Boltzmann constant, T is the temperature and η is the viscosity of the solvent. The assumption for this calculation is that the solute (EV, in our case) is a sphere undergoing Brownian motion. R h is the radius of a sphere with the same translational diffusion coefficient as that of the analyzed solute. R h depends only on the physical size of the solute and its size-related behavior/ characteristics, such as diffusion and viscosity, and is not affected by its density or molecular weight. The measurement range of 0.5-1,000 nm radius makes DLS an effective tool for measurement of the size of sEVs.
Combining AF4 with real-time DLS measurements is critical for accurate size determination. In a polydisperse sample, DLS measurement yields an average R h , and the specific information on each compositional species in a given sample is missing. However, fractionation results in the separation of solutes with different sizes, and each fraction contains only a very small admixture of different R h particles. Thus, fractionation allows the size of each species to be more accurately measured. For such monodisperse samples, the resulting autocorrelation functions are single exponentials, which are simple to interpret. Fitting the data to a single exponential function is performed in the Astra software using the Cumulants model 59 . By examining the ideal fitting to a single exponential, one can further evaluate the separation quality.
One requirement for accurate DLS measurement of R h is that the sample concentration must be high enough that the sample scatters at least three times more light than the solvent to obtain an acceptable signal/noise ratio. In particular, small molecules, such as exomeres, scatter less light and require even higher concentrations of analyte to optimize results.
In addition to DLS, static light scattering (SLS) detected by MALS measures the radius of gyration (R g ). R g is defined as the mass-averaged distance of each point in a molecule from its gravity center and is generally different from R h . Comparing R g to R h can further elucidate the compactness of a solute (i.e., empty versus filled particles). In general, the MALS detector is more sensitive than DLS monitoring and thus it will be of specific use when only a small amount of material is available for analysis.
The UV detector is used as part of our instrumentation for real-time concentration measurements. The intensity of UV absorbance can provide us an approximation of the relative abundance of different species in the sample, despite not having defined extinction coefficients for different species in the EV sample mixture. The peaks of UV absorbance are useful in guiding the choice of combining fractions of similar particles. However, we also often conduct a bicinchoninic acid assay (BCA assay) and NTA after fraction collection for quantification purposes. Once pure EVs are obtained, the extinction coefficients of each species can then be determined and used for calculation of the concentration from the UV absorbance data.
One key consideration for real-time detectors is that they must have exceptional sensitivity because of the limited amount of material passing through the detector at each single time point. In addition to the detectors mentioned above, other sensors, such as differential refractive index (dRI) and fluorescence detectors (FLDs), are often included as standard parts of the instrumentation for a variety of macromolecular characterization techniques. dRI, considered a universal concentration detector, is accurate and versatile in all types of solvents and independent of chromophores or fluorophores. FLDs are useful if autofluorescent molecules, or artificial fluorescent labeling, are present in specific subsets of EVs. It should be noted that, with additional detectors assembled inline, the fractionated particles take a longer path and more time to reach the fraction collector. As a result, diffusion of molecules will lead to broadening of peaks, dilution of fractionated samples and reduction in separation resolution. Therefore, only detectors considered essential for real-time monitoring should be installed.
Fraction collection, concentrations and characterization AF4 fractions can be collected automatically or manually for downstream post-separation characterization. We have installed the Agilent Fraction Collector (1260 series) to automatically collect fractions into 96-well plates, but similar fraction collectors can be used for accurate and reproducible fraction collections. Fractions can be collected either by volume or over time, and fractions of particles with the same identity on the basis of real-time and post-separation characterization can be further pooled together for downstream analysis. For example, in our previous work to identify exomeres and distinct subsets of exosomes 11 , we first examined representative fractions across the whole time course of fractionation by real-time DLS and post-separation TEM analysis and then pooled the fractions of particles with similar size and morphology together for further characterization. This step was also guided by the peaks of UV absorbance (indicating the most abundant fraction of each type of particle). To validate that the pooled fractions are relatively pure and not contaminated substantially by other types of adjacent particles, only fractions centered around the peaks were pooled together. Depending on the resolution of the fractionation, this fraction combination step can be empirically determined. Due to the different compositions of EV subpopulations in a given sample, occasionally the UV peaks are not identifiable and thus the fraction combination will rely more on other properties, such as size and morphology. For instance, certain cell lines secreted Exo-S and/or Exo-L at very low levels as compared with exomeres, resulting in no corresponding peaks observed in UV absorbance and/or QELS/DLS fractograms.
The individual or combined fractions can be directly used for downstream analysis or subjected to a concentration step before further characterization. We usually concentrate the collected fractions using the Amicon Ultra-series of centrifugal filter units with an Ultracel-30 (30-kDa cutoff) membrane (Millipore). Alternative means of concentration, such as tangential filtration centrifugation, direct UF, UC or IAC, can be applied depending on the needs of the downstream analysis. A variety of analyses can be performed on fractionated EVs, including BCA assay, NTA, atomic force microscopy, electron microscopy, mass spectrometry of molecular contents (e.g., proteins, lipids, glycan and metabolites), western blotting or the enzyme-linked immunosorbent assay, sequencing of genetic material (DNA and RNA), DLS measurement in batch mode and zeta-potential measurement. The functional roles of the fractionated EV subpopulations can be further investigated in vitro or in vivo.
Materials Biological materials
• B16-F10 cell line (ATCC, cat. no. CRL-6475) ! CAUTION Cell lines should be regularly checked to ensure that they are authentic and free of mycoplasma contamination. 
Reagents

Reagent setup
B16-F10 cell culture medium 500 mL of DMEM is supplemented with 10% (vol/vol) FBS (exosome-depleted), 50 units/mL penicillin-streptomycin, and 2 mM L-glutamine, and can be stored at 4°C for up to a month.
Exosome-depleted FBS
FBS is depleted of exosomes by UC at 100,000g, 10°C for 90 min and is sterilized with a Nalgene Rapid-Flow sterile disposable filter unit. Aliquots of exosome-depleted FBS can be stored long term at −20°C. ! CAUTION To avoid contamination, the rotor must first be sterilized by wiping it with 70% (vol/vol) ethanol, and all tubes for UC should be autoclaved. The entire FBS handling process should be carried out in a biological safety cabinet for tissue culture. c CRITICAL In our recent work, we have reported that a negligible amount of ENPs can be contributed by the blank medium supplemented with FBS that has been previously spun at 100,000g for 90 min to deplete the ENPs 11 . However, researchers should consider their specific study goals and decide which type of medium to use in their work; possibilities include serum-free medium, serum-free medium supplemented with specific growth factors, and medium supplemented with FBS depleted of ENPs by UC for longer durations (e.g., overnight). Consideration should take into account that the biogenesis, secretion and content of ENPs derived from cultured cells might be affected when a different medium is used for culture.
20% (vol/vol) Ethanol
Milli-Q filtered water is used to dilute ethanol to 20% (vol/vol). The final solution should be freshly made and filtered with a Nalgene Rapid-Flow sterile disposable filter unit. 0.5 mg/mL BSA solution Dissolve BSA powder in PBS at a concentration of 0.5 mg/mL and store aliquots at −20°C for longterm use.
1% (vol/vol) Contrad 70
Dilute Contrad 70 with Milli-Q water to a final concentration of 1% (vol/vol), and store at room temperature (RT,~22°C) for long-term use.
10% (wt/vol) SDS
Dissolve SDS powder in Milli-Q water at a concentration of 10% (wt/vol) (i.e., 10 g per 100 mL) and store at RT for long-term use. ! CAUTION SDS is corrosive and toxic, and can cause severe skin and eye irritation. Wear protective gloves, mask, eyeshield, faceshield and protective clothing while handling this chemical.
10% (vol/vol) Nitric acid
Dilute nitric acid with Milli-Q water to a final concentration of 10% (vol/vol), and store at RT for long-term use. ! CAUTION Nitric acid is highly corrosive and can cause severe eye and skin burns, and severe respiratory and digestive tract burns. Wear proper protective equipment (gloves, eyeshield, faceshield, clothing, respirator) and handle it in a chemical hood. The waste should be treated as a hazardous waste according to national and local hazardous waste regulations.
Equipment setup
All the parts of the AF4 instrument should be installed, configured, calibrated and certified by the manufacturers (Agilent and Wyatt Technology) before use.
Procedure
Preparation of sEVs from the conditioned medium of cell culture • Timing~3 d c CRITICAL The B16-F10 murine melanoma cell line is used as a model system in this protocol. A schematic flow diagram summarizing the key steps of the entire procedure and the flow route of AF4 is shown in Fig. 7 . 1 Seed~2.25 × 10 6 B16-F10 cells per 150 × 25 mm tissue culture dish in 25 mL of the DMEM complete medium supplemented with exosome-depleted FBS; seed a total of 12 dishes. ! CAUTION Cell lines should be regularly checked to ensure that they are authentic and free of mycoplasma contamination. We conduct monthly examination using the ATCC Universal Mycoplasma Detection Kit to ensure our cells are free of mycoplasma contamination. ! CAUTION Follow sterile procedure at this step. c CRITICAL STEP The passage number of the B16-F10 cells influences sEV composition, reflected by the changes in the relative abundance of different subsets of sEVs 11 . Therefore, avoid comparing experimental data using B16-F10 cells with big differences (e.g., a difference of 8 passages, as reported in ref. 11 ) in their passage numbers. 2 Keep the cells in a humidified tissue culture incubator for 72 h under standard conditions (5% CO 2 , 37°C). The cell culture should just reach confluence without cell death or any abnormal phenotypical changes. ! CAUTION Follow sterile procedure at this step.
c CRITICAL STEP The cells should be allowed to reach confluence in order to obtain highest sEV yield, but no cell death or a stressed phenotype (e.g., cells demonstrate a needle-like morphology or spread like a large square) should be apparent by the harvesting time to ensure the purity of the sEVs. 3 Collect the conditioned media from all 12 dishes of B16-F10 cells into 50-mL conical tubes and centrifuge at 500g at 10°C for 10 min in a table-top centrifuge. j PAUSE POINT Alternatively, the supernatant can be spun at 3,000g at 10°C for 20 min in a tabletop centrifuge, transferred to new tubes and kept at −80°C for long-term (a few months) storage. Although the overall structural integrity of ENPs is maintained after the freeze-thaw steps, how this freezing/storage step may influence the functionality of ENPs has not been well examined in the field. Researchers should decide how to proceed through the whole protocol at the listed pause points on the basis of their specific study design. However, avoid repeated freeze-thaw cycles or keeping samples on ice for a long period when feasible. 4 Transfer the supernatant to ultracentrifuge tubes (6 × 50 mL/tube) and centrifuge at 12,000g at 10°C for 20 min in a Type 45 Ti ultracentrifuge rotor (pre-chilled at 4°C). c CRITICAL STEP For UC, the opposing pair of tubes across the center of rotation need to be balanced with each other. Do not load more than 50 mL per tube to avoid sample spilling. The rotors should be kept at 4°C when not in use. 5 Transfer the supernatant to new ultracentrifuge tubes and centrifuge at 100,000g at 10°C for 70 min in the same rotor. c CRITICAL STEP At the end of each UC step, make sure the supernatant is transferred immediately to avoid the loosening of the pellet and either contaminating the supernatant or losing the pelleted samples. 6 Discard the supernatant and gently resuspend the pellets in 1 mL of ice-cold PBS. Avoid introducing air bubbles. Combine all the sample into one ultracentrifuge tube and bring the final volume to 50 mL with ice-cold PBS. 7 Centrifuge at 100,000g at 10°C for another 70 min. Resuspend the final pellet in~0.5 mL of PBS and transfer the suspension to a 1.7-mL microcentrifuge tube on ice (this is the sEV sample for AF4 fractionation in the next section). c CRITICAL STEP The pellet sometimes may be hard to break and difficult to resuspend into a homogeneous suspension. If so, the samples can be kept on ice for another 15-30 min or an extra volume of PBS can be added to the sample. Then gently pipette up and down to resuspend the samples and transfer the suspension to a 1.7-mL microcentrifuge tube for quantification. Avoid introducing air bubbles. 8 Quantify the sEV yield by taking a 10-μL aliquot and measuring the protein concentration using the Pierce BCA Protein Assay Kit. Follow the manufacturer's instructions to mix the samples or BSA standards provided by the kit with the reagents in a 96-well plate and incubate the plate at 37°C for 30 min. Read the absorbance at 562 nm using the AccuScan GO UV/Vis Microplate Spectrophotometer and calculate the concentration of the samples on the basis of the included BSA standards. Meanwhile, keep the rest of the sample on ice for same-day or next-day AF4 fractionation, or freeze at −80°C for long-term (a few months) storage. ? TROUBLESHOOTING j PAUSE POINT The samples can be frozen at −80°C for long-term storage.
Assembly of the AF4 channel • Timing~1 h 9 Before assembling the AF4 channel, select the membrane type and cutoff size (see discussion in the 'Overview of the procedure and development of the AF4 protocol: membrane choice' section; we use an RC membrane with a 10-kDa cutoff size) and a spacer of desired thickness (i.e., the channel height; we use a 490-μm spacer). 10 Rinse all parts of the AF4 channel (i.e., the top and bottom plates, spacer, membrane, O ring and frit) with Milli-Q water and assemble in the order of the top plate, spacer, membrane and bottom plates with the frit/O-ring in place). Bolt the parts together using a torque wrench, with 5-and 7.5-Nm torques applied sequentially. c CRITICAL STEP Because the sample specimen is positioned in the channel laminae very close to the membrane, it is critical that the membrane be smooth and unruffled. Wear gloves and do not bend the membrane during the assembly procedure. c CRITICAL STEP Because ethanol can cause the 'membrane swelling' phenomenon and reduce the effective channel height for fractionation, avoid exposing the membrane to ethanol. c CRITICAL STEP It is critical that the channel be tightly sealed and that its height be precise and even across the whole channel. To assemble the AF4 channel, a metered wrench such as a torque wrench should be used to apply force precisely. A good practice is to tighten the two bolts in the center first and then the ones at the corners in diagonal order. 11 Connect the tubing to the inlet, cross-flow and injection ports, but leave the outlet port unconnected. Program the flow rate settings and operate using ChemStation to start to run water at a channel flow rate of 1 mL/min through the system for at least 30 min; let the air in the channel run out from the outlet port. Then connect the tubing from the outlet to the detectors. No air bubbles should be observed in the channel. c CRITICAL STEP Do not leave the system in still aqueous solvents for a long period. For long-term storage, disassemble the membrane from the channel and maintain the system in 20% (vol/vol) ethanol. c CRITICAL STEP Keep the tubing from the channel to the detectors and the fraction collector as short as possible to reduce the peak broadening and sample dilution effects and to avoid decreases in separation resolution. ? TROUBLESHOOTING j PAUSE POINT For short-term storage, the instrument can be operated in the Night Rinse mode with a constant channel flow of 0.2 mL/min overnight, for up to a few days.
Equilibration and coating of the membrane with BSA • Timing 2-3 h 12 Change the aqueous solvent to PBS, and keep the instrument running at a channel flow of 1 mL/min for at least 30 min to 1 h. c CRITICAL STEP If the system has been maintained in ethanol or isopropanol, it should be flushed completely with water first before switching to PBS. Mixing PBS with alcohol will cause salt precipitation. ? TROUBLESHOOTING j PAUSE POINT The instrument can be operated in the Night Rinse mode overnight, with a constant channel flow of 0.2 mL/min. 13 (Optional) This step is needed only when a new membrane is installed. Load 30−40 μg of BSA (0.5 mg/mL) onto the AF4 channel and run the sample using the same AF4 method as for sEV fractionation (following Steps 14-28) with the following exceptions: there is no need to collect fractions for BSA coating, and, for the second elution step shown in Table 1 , use a constant crossflow of 3 mL/min for 15 min for BSA instead of the 45-min gradient of cross-flow. Repeat, by running BSA 1-2 more times. c CRITICAL STEP The purpose of this step is to block nonspecific binding of the samples to the membrane. The sample to be analyzed, if extra sample is available, can be used for this blocking step, too. This step is needed only when a new membrane is installed. c CRITICAL STEP At the end of the day, after all samples have been processed, turn on the Cell Operation and Maintenance Enhancing Technology (COMET) of the Dawn Heleos II detector for 30 min to clean the flow cell. ? TROUBLESHOOTING j PAUSE POINT The instrument can be operated in the Night Rinse mode overnight for up to a few days after membrane coating.
AF4 fractionation of sEVs • Timing 1-2 h per sample
14 To initialize the instrument, first open ChemStation and load the AF4 running method as described in Table 1 (the running method is programmed, edited and saved in the 'Method' module of ChemStation). 15 Set both thermostats (for the autosampler and the fraction collector) to 4°C; turn on the UV lamp for the multiple-wavelength detector (MWD) (280 nm) at least 30 min before sample analysis; turn on the laser for the Dawn Heleos II MALS detector (664 nm). 16 Turn on the fraction collector and choose the collection mode (either based on volume or time interval); install 96-well plates for fraction collection (ensure that the plates are installed according to the configuration of the fraction collector). We collect fractions at time intervals of 0.5 min, so two plates are needed to collect the fractions from one sample. c CRITICAL STEP All operations should be done using the ChemStation software, except for switching on the laser of the Dawn Heleos II MALS detector using the instrument's front control panel. 17 Open Astra 6 and start a new experiment file for data collection. For 'Configuration', select 'PBS, aqueous' as the system solvent; specify a UV wavelength of '280 nm' and enable the 'Band Broadening' option; for HELEOS, enable the 'Band Broadening' and 'Temperature Control' options; and for QELS, select 'Use QELS dithering'. For 'Procedure', specify the time interval for MALS data collection as 1 s and QELS interval as 2 s; set the duration for data collection to 60 min; then select 'Trigger on Auto-Inject'. Click the 'Run' button and the data collection will automatically start once triggered by the signal from the autosampler. 18 Prepare the AF4 input samples by adjusting the concentration of the sEVs isolated in Step 8 to 1 µg/µL with PBS. Spin at 12,000g at 4°C for 5 min to remove insoluble aggregates right before loading onto AF4. c CRITICAL STEP Pre-spinning of the sample before loading onto AF4 is critical to avoid analyzing artifacts of aggregates formed during the high-speed UC. ? TROUBLESHOOTING 19 Transfer the supernatant to a pre-chilled glass vial with a screw cap. Use a 250-µL pulled-point glass vial insert if the total volume of the sample is small, and put it onto the autosampler platform at the designated position from which the autosampler is set to pick up the sample automatically. 20 In the 'Autosampler' module of ChemStation, specify the sample volume to analyze (40-100 µL; i.e., 40-100 µg at 1 µg/µL), and then click 'Single Sample' to start the fractionation, real-time data collection (MALS, DLS and UV absorption) and fraction collection (if time slices are set to 0.5 min, the fraction volume will be 0.5 mL/fraction because the forward channel flow (i.e., the detector flow) rate is set to 1 mL/min). c CRITICAL STEP Our pilot study has determined that a range from 40 to 100 µg of B16-F10 sEVs is suitable for the current AF4 running method we have developed. This will need to be further adjusted for specific samples on the basis of their composition complexity according to the discussion in the 'Overview of the procedure and development of the AF4 protocol: Amount of input sample' section. c CRITICAL STEP It is critical to avoid allowing air bubbles into the system. Make sure that no air bubbles are trapped in the sample vial and have a larger volume of sample in the vial than the volume to be analyzed. ? TROUBLESHOOTING 21 While running of the sample, check the real flow rates in 'Wyatt Eclipse Status' panel and make sure they are close enough (within the range certified by the manufacturer) to the set flow rates. c CRITICAL STEP If the real flow rates are quite different from the set ones, something is wrong with the flow control and repair/maintenance by the manufacturer is needed to ensure the fractionation quality. c CRITICAL STEP It is critical to keep the channel flow rate (the detector flow) constant during the fractionation. Changes in the flow rate can cause artifactual signal detection by the monitors. 22 Once the fractionation is finished, take the 96-well plates out of the fraction collector and seal them, using adhesive tape. Keep the plates on ice or at 4°C for the next procedure (Steps 31-36). 23 Click 'Reset the fraction collector' so that the starting position for fraction collection is reset to its original position. Otherwise, the instrument will resume the fraction collection of the next sample from the last fraction position of the previous sample. 24 Perform real-time data analysis after each run. In Astra 6, select the experiment to be analyzed and adjust the baselines: we usually set up the baseline for the MALS signal collected from the LS 11 (90°) detector first, and then apply it to all the other detectors. Make sure to check the individual detectors to ensure that the baselines are set up correctly. 25 Select peak regions to analyze. Either select a single region or select multiple regions to be analyzed simultaneously. 26 Examine the fractionation quality by checking the fitting of the autocorrelation function at representative fractions to a single exponential model. The closer R 2 is to 1, the better the purity of the separation. 27 Open a new window of EASI Graph, and plot the R h , QELS (DLS) and UV signals versus time. The R h of the particles is deduced solely from the DLS signal, using the equations described above in the 'Experimental design' section. The R h plot displays the size of the particles eluted at each time point. The UV signal intensity can reveal the relative abundance of particles of different sizes. On the basis of these plots (and together with potential post-separation characterizations according to Steps 31-36), one can judge the AF4 separation quality and the sample composition (i.e., the relative abundance of particles of different sizes). Other types of analyses can be plotted as well by choosing different axes to display in EASI Graph according to the need. c CRITICAL STEP Besides real-time UV detection, other means of quantification, such as BCA assay and NTA analysis, can be used to measure the concentration of the fractions (Steps 31-36) . c CRITICAL STEP The sample concentration should be high enough to scatter enough light for accurate R h determination, especially for small size particles because they scatter much less light. ? TROUBLESHOOTING 28 To fractionate more of the same biological sample or a new sample, install new 96-well fraction collection plates and start fractioning the next sample by repeating Steps 17-27. c CRITICAL STEP If multiple samples need to be analyzed, but the collection of separated fractions is not required, a 'Sequence' (a series of methods and samples programmed to be run sequentially) can be run instead of the method for a single sample. Users can refer to the manual from the manufacturer for details. 29 Run a blank control of the running buffer (i.e., PBS or another type of running buffer used to analyze the samples) using the same AF4 running method for the samples on the same day by following Steps 17-27. This blank control can help evaluate aspects of the instrument performance, such as background noise level, and identify systemic problems that may influence sample analysis. c CRITICAL STEP ENPs isolated from the equal volume of blank medium can be run as a control in parallel to those isolated from the conditioned medium of specific cell lines. This will yield the information on the potential contamination of ENPs present in the medium in the final ENP product. First, pre-rinse the filter columns by adding 5 mL (for an Ultra-4 filter column) or 15 mL (for an Ultra-15 filter column) of ice-cold PBS followed by spinning at 3,700g at 4°C for 5 min. Discard the flow-through and liquid remaining in the top filter columns. 33 Transfer pooled fractionated samples to the top filter column and spin at 3,700g at 4°C for 7-8 min. Retain the concentrated samples in the top filter columns and discard the flow-through buffer that collects at the bottom of the collection tubes. 34 Repeat
Step 33 until each sample is concentrated to the desired volume (e.g., <100 µL for an Ultra-4 filter column and <200 µL for an Ultra-15 filter column). For each sample, the same filter column can be repeatedly loaded and spun to concentrate the sample. 35 Transfer the concentrated samples to 1.7-mL microcentrifuge tubes on ice. Record the volume and take an aliquot (5-10 µL) for BCA measurements to determine the protein concentration. 36 Store the concentrated samples on ice for short-term storage (up to 2-3 d) or frozen at −80°C for long-term (a few months) storage. Downstream molecular characterizations (see discussion in 'Experimental design' section) and functional study can be performed on these concentrated fractionated samples. c CRITICAL STEP For an unknown sample that is analyzed using AF4 for the first time, we check the morphology of representative individual fractions by TEM first before pooling fractions together for further analysis. c CRITICAL STEP It is possible that particles with the same hydrodynamic size but different morphology elute together from AF4. Other means to separate these particles on the basis of their distinct biophysical/biochemical properties (such as density, surface molecule expression and charge) should be explored in combination with AF4 for further fractionation. c CRITICAL STEP We usually pool fractions together on the basis of their hydrodynamic size, morphology and purity of representative fractions. If baseline separation of two adjacent, distinct populations of particles is not achieved, avoid collecting those fractions in the 'valley' between the peaks of two populations for further characterization. ? TROUBLESHOOTING
Troubleshooting
Troubleshooting advice can be found in Table 2 . Seed a higher number of cells per plate or use a larger number of plates or a longer cell culture time The sEV pellet from 100,000g UC was lost Remove the supernatant from the sEV pellet immediately after 100,000g UC Abnormally high sEV yield Contamination due to inefficient washing Resuspend the pellet from Step 6 completely and use a large volume of PBS to wash in Step 7 Too much carryover of medium in Step 6 Invert the tubes from Step 6 on a paper towel to drain the leftover medium or aspirate it using the vacuum system before washing with PBS Contamination of the pellet from 12,000g UC 
Anticipated results
We have provided a detailed protocol for optimal sEV preparation and fractionation via AF4. We have highlighted and discussed the key steps for successful AF4 separation: (i) the preparation of sEVs from conditioned medium of cell culture; (ii) development and optimization of the AF4 running methods; (iii) real-time data analysis and fraction collection for post-separation characterization. Pre-stratification of the sEVs using methods such as UC is critical to reduce the complexity of the samples to be analyzed in their particle composition. This allows enough material for each subpopulation of sEVs present in the samples to be analyzed by a single run of AF4. Otherwise, a series of AF4 methods for best separation of particles within different size ranges must be adapted. Another key factor for successful AF4 analysis and fractionation is the amount of input sample loaded onto the AF4 system. Overloading the system will result in poor resolution and inefficient separation of nanoparticles, whereas loading too small a sample will lead to poor signal detection and inaccurate data deduction, as shown in Fig. 6 .
We have discussed five major parameters for AF4 running method optimization: cross-flow, channel height, focus time, loading amount and membrane type (Figs. 2-5) . A representative AF4 fractionation profile of B16-F10-derived sEVs is shown in Fig. 8 . On the basis of the method described here, three major subpopulations of sEVs were identified (Fig. 8a, i. e., exomeres, Exo-S and Exo-L, corresponding to peaks P2, P3 and P4, respectively). The autocorrelation function is a key factor in determining the purity of each fraction (Fig. 8b) . The separated particles can be further recovered and usually need further concentration for a variety of post-separation analyses, such as TEM, NTA, BCA assay, biophysical/biochemical property characterization, molecular composition determination and functional studies. Figure 8c shows TEM imaging analysis of combined fractions for B16-F10 exomeres, Exo-S and Exo-L, revealing the distinct morphology of each sEV subset. As a reference, an estimation has been calculated using three independent experiments for the final yield of each subpopulation from two representative cell lines (B16-F10 and AsPC-1) (Supplementary Fig. 1 ). Resulting from an input of 100 μg of sEVs, the yields of exomeres, Exo-S and Exo-L from B16-F10 are 2.7 μg, 10.7 μg and 5.2 μg, respectively; and 8.4 μg, 4.5 μg and 1.7 μg, respectively, from AsPC-1. The concentration of an individual fraction immediately post AF4 fractionation is too dilute to be measured accurately using the BCA assay. However, a rough estimation by back calculation yields the following average concentration for each subpopulation: 0.36 μg/mL, 0.88 μg/mL and 0.66 μg/mL of exomeres, Exo-S and Exo-L, respectively, from B16-F10; and 2.8 μg/mL, 0.76 μg/mL and 0.27 μg/mL of exomeres, Exo-S and Exo-L, respectively from AsPC-1. Owing to the loss of samples during the concentration step, the original concentration of an individual fraction should be slightly higher. The yield of each subpopulation depends on the specific biological sample (e.g., different cell lines and cell culture conditions) and sample preparation. The stringency for combining fractions for each subpopulation and the recovery rate of the concentration step must be considered as well.
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
All Astra 6 data files used for producing the plots presented in figures have been deposited at https://figshare.com/s/6f22aede51fb279a3f81. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Sample size
Due to the fact that this protocol describes nanoparticle fractionation methods, the sample size is not relevant.
Data exclusions No data exclusions
Replication
All replicate experiments are successful Randomization Due to the fact that this protocol describes nanoparticle fractionation methods, sample randomization is not relevant or needed.
Blinding
Due to the fact that this protocol describes nanoparticle fractionation methods, sample blinding is not relevant or needed.
Reporting for specific materials, systems and methods Mycoplasma contamination
Cell lines were tested and confirmed to be free of mycoplasma contamination
Commonly misidentified lines (See ICLAC register)
Name any commonly misidentified cell lines used in the study and provide a rationale for their use.
